Home LiteratureArticle Details
PMID: 19136941 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death.

Cell death and differentiation ·Vol. 16 ·No. 4 ·2009-04-00 ·Pages 515-23

Burton TR, Gibson SB

Abstract

Bcl-2 nineteen-kilodalton interacting protein (BNIP3) is a BH-3-only Bcl-2 family member whose expression levels increase during stress such as hypoxia through hypoxia-inducing factor-1-dependent or -independent mechanisms. When BNIP3 expression is induced, it localizes to the mitochondria and triggers a loss of membrane potential, and an increase in the reactive oxygen species production, which often leads to cell death. Cells under normal growth conditions suppress BNIP3 expression through transcriptional repression. There is considerable debate in the literature regarding what type of cell death is induced by BNIP3. It has been observed that BNIP3 could induce necrosis, autophagy and/or apoptosis. In contrast, other studies indicate that BNIP3 could promote cell survival. Besides its cell death regulation, BNIP3 plays a key role in the pathogenicity of many diseases. In cardiac infarction, loss of BNIP3 expression has been shown to reduce the number of damaged cardiomyocytes after ischemia and reperfusion. BNIP3 expression also plays an important role in the deregulation of cell death in many cancers. In this review, we will discuss the different and often contradictory mechanisms of BNIP3 regulation of cell death and the role that BNIP3 may play in diseases.

MeSH Terms
Animals Apoptosis/physiology Cell Death/physiology Gene Expression Regulation, Neoplastic Humans Membrane Proteins/metabolism Models, Biological Necrosis Neoplasms/physiopathology Proto-Oncogene Proteins/metabolism
Chemicals
BNIP3 protein, human Membrane Proteins Proto-Oncogene Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Burton T R
Manitoba Institute of Cell Biology, 675 McDermot Avenue, Winnipeg, Manitoba, Canada.
Gibson S B
References (79)
79 references, click to expand
  1. BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF.
    Oncogene. 2003 Jul 24;22(30):4734-44 PMID: 12879018
  2. Molecular regulation of cardiac myocyte adaptations to chronic hypoxia.
    J Mol Cell Cardiol. 1992 Jul;24(7):741-51 PMID: 1328657
  3. Thymidine phosphorylase inhibits the expression of proapoptotic protein BNIP3.
    Biochem Biophys Res Commun. 2008 May 30;370(2):220-4 PMID: 18359286
  4. Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours.
    Br J Cancer. 2005 Mar 28;92(6):1165-72 PMID: 15756280
  5. Concanavalin A induces autophagy in hepatoma cells and has a therapeutic effect in a murine in situ hepatoma model.
    Hepatology. 2007 Feb;45(2):286-96 PMID: 17256764
  6. Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo.
    Cancer Lett. 2006 Dec 8;244(2):274-88 PMID: 16500022
  7. Regulation of Bnip3 death pathways by calcium, phosphorylation, and hypoxia-reoxygenation.
    Antioxid Redox Signal. 2007 Sep;9(9):1309-15 PMID: 17638546
  8. Bnip3 mediates the hypoxia-induced inhibition on mammalian target of rapamycin by interacting with Rheb.
    J Biol Chem. 2007 Dec 7;282(49):35803-13 PMID: 17928295
  9. The carboxy terminal C-tail of BNip3 is crucial in induction of mitochondrial permeability transition in isolated mitochondria.
    Arch Biochem Biophys. 2002 Feb 15;398(2):147-52 PMID: 11831844
  10. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors.
    Cancer Res. 2001 Sep 15;61(18):6669-73 PMID: 11559532
  11. Establishment and gene analysis of an oxaliplatin-resistant colon cancer cell line THC8307/L-OHP.
    Anticancer Drugs. 2007 Jul;18(6):633-9 PMID: 17762391
  12. Nuclear factor-kappaB-mediated cell survival involves transcriptional silencing of the mitochondrial death gene BNIP3 in ventricular myocytes.
    Circulation. 2005 Dec 13;112(24):3777-85 PMID: 16344406
  13. Unique dimeric structure of BNip3 transmembrane domain suggests membrane permeabilization as a cell death trigger.
    J Biol Chem. 2007 Jun 1;282(22):16256-66 PMID: 17412696
  14. Expression of BNIP3 correlates with hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha and the androgen receptor in prostate cancer and is regulated directly by hypoxia but not androgens in cell lines.
    Prostate. 2008 Feb 15;68(3):336-43 PMID: 18163427
  15. Myocardial ischemia and reperfusion.
    Monogr Pathol. 1995;37:47-80 PMID: 7603485
  16. A potential molecular link between aerobic glycolysis and cancer.
    Cell Cycle. 2006 Feb;5(4):343-4 PMID: 16479166
  17. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3.
    Oncogene. 2005 Feb 3;24(6):980-91 PMID: 15592527
  18. Expression of the cell death genes BNip3 and NIX in ductal carcinoma in situ of the breast; correlation of BNip3 levels with necrosis and grade.
    J Pathol. 2003 Dec;201(4):573-80 PMID: 14648660
  19. The C. elegans orthologue ceBNIP3 interacts with CED-9 and CED-3 but kills through a BH3- and caspase-independent mechanism.
    Oncogene. 2000 Nov 16;19(48):5453-63 PMID: 11114722
  20. Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3.
    Autophagy. 2008 Feb;4(2):195-204 PMID: 18059169
  21. A unique pathway of cardiac myocyte death caused by hypoxia-acidosis.
    J Exp Biol. 2004 Aug;207(Pt 18):3189-200 PMID: 15299040
  22. BNIP3 as a progression marker in primary human breast cancer; opposing functions in in situ versus invasive cancer.
    Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):467-74 PMID: 17255267
  23. Death by design: apoptosis, necrosis and autophagy.
    Curr Opin Cell Biol. 2004 Dec;16(6):663-9 PMID: 15530778
  24. Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice.
    J Clin Invest. 2007 Oct;117(10):2825-33 PMID: 17909626
  25. Upregulation of BNIP3 and translocation to mitochondria mediates cyanide-induced apoptosis in cortical cells.
    Neuroscience. 2007 Nov 30;150(1):159-67 PMID: 17980495
  26. BNIP3 upregulation and EndoG translocation in delayed neuronal death in stroke and in hypoxia.
    Stroke. 2007 May;38(5):1606-13 PMID: 17379825
  27. Inducible expression of BNIP3 provokes mitochondrial defects and hypoxia-mediated cell death of ventricular myocytes.
    Circ Res. 2002 Aug 9;91(3):226-31 PMID: 12169648
  28. Biochemical determinants of apoptosis and necrosis.
    Toxicol Lett. 1998 Nov 12;99(3):157-68 PMID: 9862281
  29. Adenovirus E1B-19K/BCL-2 interacting protein BNIP3 contains a BH3 domain and a mitochondrial targeting sequence.
    J Biol Chem. 1998 May 15;273(20):12415-21 PMID: 9575197
  30. Glucocorticoids exacerbate hypoxia-induced expression of the pro-apoptotic gene Bnip3 in the developing cortex.
    Neuroscience. 2007 Jan 19;144(2):482-94 PMID: 17110051
  31. Selective silencing of the hypoxia-inducible factor 1 target gene BNIP3 by histone deacetylation and methylation in colorectal cancer.
    Oncogene. 2007 Jan 4;26(1):132-41 PMID: 16799636
  32. Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil.
    Int J Oncol. 2004 May;24(5):1279-88 PMID: 15067352
  33. BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1alpha pathway and prognosis.
    J Clin Pathol. 2008 Feb;61(2):217-20 PMID: 17513511
  34. Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53.
    J Clin Invest. 1999 Aug;104(3):239-52 PMID: 10430605
  35. Nipping at cardiac remodeling.
    J Clin Invest. 2007 Oct;117(10):2751-3 PMID: 17909620
  36. Mutational and expressional analysis of BNIP3, a pro-apoptotic Bcl-2 member, in gastric carcinomas.
    APMIS. 2007 Nov;115(11):1274-80 PMID: 18092960
  37. BNIP3 expression in follicular lymphoma.
    Histopathology. 2007 Apr;50(5):555-60 PMID: 17394490
  38. Bnip3 functions as a mitochondrial sensor of oxidative stress during myocardial ischemia and reperfusion.
    Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H2025-31 PMID: 18790835
  39. Effect of combined therapy with low-dose 5-aza-2'-deoxycytidine and irinotecan on colon cancer cell line HCT-15.
    Ann Surg Oncol. 2007 May;14(5):1752-62 PMID: 17195906
  40. Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival.
    Acta Neuropathol. 2007 Mar;113(3):325-37 PMID: 17265049
  41. Autophagy as a protective response to Bnip3-mediated apoptotic signaling in the heart.
    Autophagy. 2006 Oct-Dec;2(4):307-9 PMID: 16874059
  42. S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer.
    Cancer Res. 2007 Jul 15;67(14):6786-95 PMID: 17638890
  43. Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy.
    Cell Death Differ. 2007 Jan;14(1):146-57 PMID: 16645637
  44. The cell cycle factor E2F-1 activates Bnip3 and the intrinsic death pathway in ventricular myocytes.
    Circ Res. 2008 Feb 29;102(4):472-9 PMID: 18096822
  45. The Bcl-2 family pro-apoptotic molecule, BNIP3 regulates activation-induced cell death of effector cytotoxic T lymphocytes.
    Immunology. 2003 Sep;110(1):10-7 PMID: 12941136
  46. Bcl-2/adenovirus E1B 19 kDa interacting protein-3 knockdown enables growth of breast cancer metastases in the lung, liver, and bone.
    Cancer Res. 2005 Dec 15;65(24):11689-93 PMID: 16357180
  47. Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer.
    Cancer Sci. 2006 Jul;97(7):582-8 PMID: 16827797
  48. BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy.
    Mol Cell Biol. 2007 Sep;27(17):6229-42 PMID: 17576813
  49. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3.
    Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12825-30 PMID: 12226479
  50. Increased BNip3 and decreased mutant p53 in cisplatin-sensitive PDT-resistant HT29 cells.
    Biochem Biophys Res Commun. 2005 Jun 3;331(2):648-57 PMID: 15850808
  51. Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis.
    Oncogene. 2005 Jun 23;24(27):4421-32 PMID: 15856026
  52. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells.
    Cancer Res. 2008 Jan 1;68(1):44-54 PMID: 18172295
  53. Effects of short- and long-term hypobaric hypoxia on Bcl2 family in rat heart.
    Int J Cardiol. 2006 Apr 14;108(3):376-84 PMID: 16005992
  54. Sequence dependence of BNIP3 transmembrane domain dimerization implicates side-chain hydrogen bonding and a tandem GxxxG motif in specific helix-helix interactions.
    J Mol Biol. 2006 Dec 15;364(5):974-90 PMID: 17049556
  55. Upregulation of BNIP3 promotes apoptosis of lung cancer cells that were induced by p53.
    Biochem Biophys Res Commun. 2006 Jul 28;346(2):501-7 PMID: 16765911
  56. Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance.
    Pathol Annu. 1982;17 Pt 2:229-59 PMID: 7182752
  57. Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells.
    Cancer Res. 2004 Jun 15;64(12):4286-93 PMID: 15205343
  58. The pro-cell death Bcl-2 family member, BNIP3, is localized to the nucleus of human glial cells: Implications for glioblastoma multiforme tumor cell survival under hypoxia.
    Int J Cancer. 2006 Apr 1;118(7):1660-9 PMID: 16217754
  59. Nitric oxide induces BNIP3 expression that causes cell death in macrophages.
    Biochem Biophys Res Commun. 2004 Aug 20;321(2):298-305 PMID: 15358175
  60. Hypoxia and expression of the proapoptotic regulator BNIP3 in cervical cancer.
    Int J Gynecol Cancer. 2006 May-Jun;16(3):1314-20 PMID: 16803523
  61. Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells.
    Blood. 2004 Nov 15;104(10):3126-35 PMID: 15271793
  62. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes.
    J Clin Invest. 1997 Jun 1;99(11):2635-43 PMID: 9169493
  63. BNip3 and signal-specific programmed death in the heart.
    J Mol Cell Cardiol. 2005 Jan;38(1):35-45 PMID: 15623420
  64. Bnip3 mediates mitochondrial dysfunction and cell death through Bax and Bak.
    Biochem J. 2007 Aug 1;405(3):407-15 PMID: 17447897
  65. Acetyl-Coenzyme A acyltransferase 2 attenuates the apoptotic effects of BNIP3 in two human cell lines.
    Biochim Biophys Acta. 2008 Jun;1780(6):873-80 PMID: 18371312
  66. Evidence of oxidative stress-induced BNIP3 expression in amyloid beta neurotoxicity.
    Brain Res. 2007 Mar 23;1138:221-30 PMID: 17274962
  67. Distinct pathways regulate proapoptotic Nix and BNip3 in cardiac stress.
    J Biol Chem. 2006 Jan 20;281(3):1442-8 PMID: 16291751
  68. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore.
    Mol Cell Biol. 2000 Aug;20(15):5454-68 PMID: 10891486
  69. BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites.
    J Biol Chem. 2000 Jan 14;275(2):1439-48 PMID: 10625696
  70. Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer.
    Clin Cancer Res. 2005 Feb 1;11(3):1021-7 PMID: 15709167
  71. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia.
    Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9082-7 PMID: 10922063
  72. Transcriptional silencing of the death gene BNIP3 by cooperative action of NF-kappaB and histone deacetylase 1 in ventricular myocytes.
    Circ Res. 2006 Dec 8;99(12):1347-54 PMID: 17082476
  73. Elucidation of the relationship of BNIP3 expression to gemcitabine chemosensitivity and prognosis.
    World J Gastroenterol. 2007 Sep 14;13(34):4593-7 PMID: 17729412
  74. BNIP3alpha: a human homolog of mitochondrial proapoptotic protein BNIP3.
    Cancer Res. 1999 Feb 1;59(3):533-7 PMID: 9973195
  75. Differentially regulated functional gene clusters identified during ischemia and reperfusion in isolated cardiac myocytes using coverslip hypoxia.
    J Pharmacol Toxicol Methods. 2008 Jan-Feb;57(1):42-51 PMID: 17928241
  76. Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer.
    Cancer Res. 2004 Aug 1;64(15):5338-46 PMID: 15289340
  77. Nix and Nip3 form a subfamily of pro-apoptotic mitochondrial proteins.
    J Biol Chem. 1999 Jan 1;274(1):7-10 PMID: 9867803
  78. Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy.
    Nat Med. 2002 Jul;8(7):725-30 PMID: 12053174
  79. BNIP3 expression is linked with hypoxia-regulated protein expression and with poor prognosis in non-small cell lung cancer.
    Clin Cancer Res. 2004 Aug 15;10(16):5566-71 PMID: 15328198
Article Info
Journal
Cell death and differentiation
Abbr.
Cell Death Differ
ISSN
1476-5403
Published
2009-04-00
Epub
2009-00-09
Pages
515-23
Language
English
Region
England
NLM ID
9437445
PMCID
PMC3158804
Subset
IM
Grants
CIHR · 64330 · Canada
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com